Therapy News and Research

RSS

Edixomed develops revolutionary technology for tackling antimicrobial resistance

New results announced at the recent Wounds UK conference and Eurobiofilms 2017 congress, have provided the latest evidence that Edixomed, a UK biotechnology company, has developed a revolutionary new technology for tackling the enormous public health challenge of antimicrobial resistance (AMR).

22 Dec 2017

Second edition of Open Accelerator program unveils winning Life Science start-ups

Zcube today announces the winners of the second edition of its Open Accelerator program aimed at Life Science start-ups and entirely supported by the Italian company: Zambon.

22 Dec 2017

Study finds new marker to detect fatal breast cancer

A new study conducted at the University College London, UK, found a new marker that has the capacity to help diagnose fatal breast cancer up to one year earlier than existing methods.

22 Dec 2017

Tumor growth traits can influence response to cancer drugs, study finds

Individual tumors respond differently to cancer drugs, if at all. Until now, it remained a mystery why tumors have different reactions to the exact same therapy. But a new study at the USC Viterbi School of Engineering finds that tumor growth properties can influence response to cancer drugs.

21 Dec 2017

Drugs alone may not improve chances of successful quitting among smokers, study suggests

Pharmaceutical interventions are routinely prescribed to help people quit smoking. However, a new study by University of California San Diego School of Medicine researchers suggests that, despite promising results in clinical trials, smoking cessation drugs alone may not be improving the chances of successful quitting among smokers in general.

21 Dec 2017

Study findings could lead to less expensive and more effective cancer treatments

The latest generation of cancer treatments spring from the discovery that the human immune system is able to beat the disease. Like Dorothy in "The Wizard of Oz," what research teams around the world have spent decades searching for was right in their own backyard all along.

20 Dec 2017

Clinical benefit of new cancer therapies may justify the expensive price

Researchers from the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, selected to estimate the cost-effectiveness of the newly approved CAR-T therapies, have found the clinical benefit may justify the expensive price.

20 Dec 2017

Stem cells remain healthy following low-dose X-ray exposure, say biophysicists

Biophysicists have shown that following low-dose exposure to X-rays (at 80 milligrays), stem cells remain healthy, proliferate, and do not accumulate DNA damage to be passed on to their progeny. The paper was published in the journal Aging.

20 Dec 2017

Antidepressant may also alleviate multiple sclerosis symptoms

The antidepressant clomipramine may also alleviate symptoms of multiple sclerosis (MS), specifically in its progressive form, i.e. when it occurs without relapses or remissions.

20 Dec 2017

Unmarried heart disease patients have higher risk of death

Compared to married heart disease patients, being unmarried was associated with a higher risk of dying, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.

20 Dec 2017

New on-demand therapy app LARKR introduces additional features

New on-demand therapy app LARKR today announced the addition of several new features, including mindfulness challenges and reminders that will provide a more well-rounded mental health care experience.

20 Dec 2017

Child life services serve as major component of pediatric hospital-based care

Being in the hospital is no bed of roses. Especially for kids. "For many children, the hospital can be a scary place," said Linda Nicolotti, Ph.D., director of pediatric psychology at Brenner Children's Hospital, part of Wake Forest Baptist Medical Center.

20 Dec 2017

RayStation chosen for new ultra-modern cancer center in Quebec

CRIC (Centre régional intégré de cancérologie) is an initiative to create a new ultra-modern cancer center in Levis, close to Quebec City. The facility will serve the Chaudière-Appalaches region. It will have the capacity to treat up to 1,700 patients per year, with the first treatments expected to take place in April 2019.

20 Dec 2017

Scientists develop test to predict treatment outcomes in patients with childhood leukemia

UC San Francisco physician-scientists have developed a test that can predict how patients with juvenile myelomonocytic leukemia (JMML) will respond to treatment, and may also be able to identify patients who are likely to recover spontaneously with little to no treatment.

19 Dec 2017

Study explores use of radiosurgery in lung cancer patients with multiple brain metastases

Although targeted therapies have produced dramatic advances in our ability to control some types of advanced lung cancer, growth of the disease in the brain remains a major problem.

19 Dec 2017

Study finds racial, socioeconomic barriers to accessing life-saving treatment for metastatic cancer

Increasing use of a potentially life-saving treatment for metastatic cancer is leaving too many vulnerable patients behind, according to a new study from Yale Cancer Center/Smilow Cancer Hospital published in JNCCN – Journal of the National Comprehensive Cancer Network.

19 Dec 2017

New scalp device delivering electric fields improves survival in patients with glioblastoma

A device attached to a patient's scalp that delivers a continuous dose of low-intensity electric fields improves survival and slows the growth of a deadly brain tumor, according to a new clinical trial led by a Northwestern Medicine scientist and published Dec. 19 in the journal JAMA.

19 Dec 2017

FDA approves new gene therapy targeting rare form of inherited vision loss

The U.S. Food and Drug Administration today approved Luxturna (voretigene neparvovec-rzyl), a new gene therapy, to treat children and adult patients with an inherited form of vision loss that may result in blindness.

19 Dec 2017

Study finds combination therapy as effective strategy to treat ovarian cancers

Researchers at The Wistar Institute have found that combining PARP inhibitors, recently approved for the treatment of BRCA-mutant ovarian cancer, with another small molecule inhibitor was effective to treat ovarian cancers without BRCA1 and BRCA2 gene mutations.

19 Dec 2017

Electric fields therapy leads to better overall, progression-free survival in glioblastoma patients

Patients with glioblastoma, an aggressive brain tumor who received a type of electric fields therapy that interferes with cell division had better overall survival and survival without progression of the tumor compared to standard chemotherapy.

19 Dec 2017

Therapy News and Research

Edixomed develops revolutionary technology for tackling antimicrobial resistance

Second edition of Open Accelerator program unveils winning Life Science start-ups

Study finds new marker to detect fatal breast cancer

Tumor growth traits can influence response to cancer drugs, study finds

Drugs alone may not improve chances of successful quitting among smokers, study suggests

Study findings could lead to less expensive and more effective cancer treatments

Clinical benefit of new cancer therapies may justify the expensive price

Stem cells remain healthy following low-dose X-ray exposure, say biophysicists

Antidepressant may also alleviate multiple sclerosis symptoms

Unmarried heart disease patients have higher risk of death

New on-demand therapy app LARKR introduces additional features

Child life services serve as major component of pediatric hospital-based care

RayStation chosen for new ultra-modern cancer center in Quebec

Scientists develop test to predict treatment outcomes in patients with childhood leukemia

Study explores use of radiosurgery in lung cancer patients with multiple brain metastases

Study finds racial, socioeconomic barriers to accessing life-saving treatment for metastatic cancer

New scalp device delivering electric fields improves survival in patients with glioblastoma

FDA approves new gene therapy targeting rare form of inherited vision loss

Study finds combination therapy as effective strategy to treat ovarian cancers

Electric fields therapy leads to better overall, progression-free survival in glioblastoma patients

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News